MKDW vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 25, 2026

MKDW

39.8
AI Score
VS
MKDW Wins

NIVF

31.6
AI Score

Investment Advisor Scores

MKDW

40score
Recommendation
AVOID NEW MONEY

NIVF

32score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric MKDW NIVF Winner
Forward P/E 0 0.0071 Tie
PEG Ratio 0 0 Tie
Revenue Growth 12.9% -4.7% MKDW
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 39.8/100 31.6/100 MKDW
Profit Margin -92.6% 24.2% NIVF
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED NIVF

Relative Price Performance (Last 90 Days)

MKDW 1M: -77.4% · 3M: -96.9% NIVF 1M: +169.9% · 3M: +39.0%

Current Technical Phase

MKDW

Markdown
Sell / avoid

Price below a falling SMA50 (slope -43.5%), weak momentum, RSI 20

RSI (14): 20.3 · Price: $0.35

NIVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 77

RSI (14): 76.8 · Price: $1.46

Fundamentals Snapshot

Metric MKDW NIVF
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.2% 0.2%
Operating Margin -4.1% -1.8%
EPS -1.54 -26766.46
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MKDW is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.